"We are a full service Ophthalmology practice, specializing in Cataract and Refractive Surgery including iLASIK, PRK, ICL and Refractive Lens Exchange. Our physicians are subspecialty fellowship-trained in Cornea and External Diseases and Glaucoma, and offer participation in clinical research studies. We offer comprehensive eye exams, glasses and contact lenses."

During the past decade, Fine, Hoffman, and Packer conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fine, Hoffman, and Packer" #1 sponsor was "Carl Zeiss Meditec, Inc." with 3 trials, followed by "Allergan" with 2 trials sponsored, "Mark Packer, MD, FACS" with 2 trials sponsored, "VisionCare, Inc." with 2 trials sponsored and "ICON Bioscience Inc" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fine, Hoffman, and Packer" #1 collaborator was "Abbott Medical Optics" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Fine, Hoffman, and Packer" are "AMD" (1 trials), "Cataract" (1 trials), "Cataracts" (1 trials), "Dry Eye Syndromes" (1 trials) and "Glaucoma, Open-Angle" (1 trials). Many other conditions were trialed in "Fine, Hoffman, and Packer" in a lesser frequency.

Most popular intervention types in "Fine, Hoffman, and Packer" are "Device" (8 trials), "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AGN-195263 0.01%" (1 trials), "AGN-195263 0.03%" (1 trials), "AGN-195263 0.1%" (1 trials), "AGN-195263 Vehicle" (1 trials) and "Active Comparator: Timolol 0.5%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fine, Hoffman, and Packer" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Fine, Hoffman, and Packer". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 10 completed trials in Fine, Hoffman, and Packer, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Fine, Hoffman, and Packer, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".